NATEC Medical Launches a Complete Peripheral Transluminal Angioplasty Catheter Range on OEM/OBL Basis
April 29, 2014, Reduit, Mauritius — NATEC Medical announced CE Mark approval of a complete catheter-based solution for peripheral arterial disease (PAD) treatment. NATEC Medical is launching three different percutaneous transluminal angioplasty (PTA) platforms:
- Ebony 014” Rx and OTW
- Ebony 018” OTW
- Ebony 035” OTW
“Peripheral vascular diseases (PVDs) are clearly a steadily growing indication, mainly due to the
aging of the population and an in-depth life style modification. The prevalence of PVD
increases with the age for both men and women. On top of that, when you add risk factors such
as smoking, cholesterol and HBP, we are clearly facing a health care situation,” said Miroslav
SECEROV, NATEC Medical Sales & Marketing VP. “Angioplasty is currently one of the most
efficient treatments, doing as well as surgery, and even better in some specific cases, but the
choice of the primary device is, and will remain, critical. Physicians need to have several options
available and a complete treatment solution.”
Having the CE mark on Ebony range is the first step of the NATEC Medical global regulatory
approach, where 510k & ANVISA applications are as important as the width of the range.
The 510k approval on the full range is expected by Q3 2014.
About NATEC Medical
Over the past 15 years, the Mauritius-based PTCA and PTA balloon catheters manufacturer and
distributor Natec Medical has proven to be the global partner for the OEM medical devices market,
including drug-eluting balloon platforms. New orientations are driven by strategic business alliances, extended product portfolios and new value services, amongst which is a complete crimping department with all the latest machines available. NATEC Medical is a privately held company.
Miroslav SECEROV – VP Sales & Marketing
Ebène Business Park
Tel : +230 52 52 37 52 / +33 688 06 23 38
Skype : miroslav.secerov